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===================

The human intestine is colonized by a large and diverse community of microorganisms that exert protective, structural, and metabolic effects on the intestinal mucosa and other systems of the human host ([@B1]). The majority of these microbes belong to the bacterial phyla *Firmicutes* and *Bacteroidetes* ([@B2]). Species of the latter group account for about 50% of the 16S rRNA gene sequences detected in human fecal samples ([@B3]) and are considered to play a significant role in the utilization of complex carbohydrates and the regulation of mucosal immunity ([@B4]). At the same time, certain members of the *Bacteroidetes* group can cause various opportunistic infections ([@B5]).

The genus *Coprobacter*, described in 2013, is classified within the family *Porphyromonadaceae*, the order *Bacteroidales*, and the phylum *Bacteroidetes*. Currently, it comprises a single species, *Coprobacter fastidiosus*, isolated from the feces of a healthy infant ([@B6]). These Gram-negative obligate anaerobic bacteria differ from members of a closely related genus, *Barnesiella*, by their ability to produce propionic acid, their lower G+C content, and the composition of their major fatty acids. The abundance of 16S rRNA sequences of *C. fastidiosus* in metagenomic studies suggests this species is highly prevalent in human intestinal microbiota ([@B6]).

A paired-end library of *C. fastidiosus* NSB1^T^ was made using a Nextera DNA sample preparation kit (Illumina). The library was quality checked using the Agilent high sensitivity DNA kit and the 2100 Bioanalyzer (Agilent Technologies). Sequencing was performed on a MiSeq benchtop sequencer using the MiSeq reagent kit version 1, with a read length of 150 bases on each strand.

The reads were assembled *de novo* using the CLC Genomics Workbench 6.0, with a word size of 19 and a bubble size of 143. The overall length of the contigs is 3.4 Mb, the N~50~ is 167 kb, and the G+С content is 38.3%. The genome was annotated using the NCBI Prokaryotic Genome Annotation Pipeline ([@B7]). Metabolic pathways were reconstructed using KAAS ([@B8]) and manually curated.

The predicted metabolic pathways are typical for chemoorganoheterotrophic bacteria. An analysis of the core metabolism genes suggests the presence of a Wood-Werkman cycle, a partial tricarboxylic acid (TCA) cycle lacking a succinyl-coenzyme A (CoA) hydrolase, as previously described for *Propionibacterium freudenreichii*, and a respiratory chain that can be used in the production of propionic acid ([@B9]). Acetyl-CoA is likely synthesized by pyruvate-flavodoxin oxidoreductase (gene NSB1T_03985). The presence of the genes coding for cytochrome *bd* oxidase (NSB1T_14095 and NSB1T_14100) may be indicative of the ability of the strain to utilize oxygen at low concentrations for energy production ([@B10], [@B11]).

No prophage sequences were found using PHAST ([@B12]). The resistance of *C. fastidiosus* NSB1^T^ to β-lactam antibiotics ([@B6]) was linked to the presence of several possible β-lactamase genes (NSB1T_03925, NSB1T_10950, NSB1T_07185, and NSB1T_06290). However, despite the presence of a predicted chloramphenicol acetyltransferase gene (NSB1T_01810), the strain NSB1^T^ is sensitive to chloramphenicol ([@B6]).

The availability of this genomic sequence makes possible further studies to reveal molecular factors allowing for the colonization of human gut by *C. fastidiosus*, as well as to understand the functional position of this recently discovered species within the human intestinal microbial consortium.
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This whole-genome shotgun project has been deposited to DDBJ/EMBL/GenBank under the accession no. [AWWG00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AWWG00000000). The version described in this paper is the first version, AWWG01000000.
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